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Arylamine N-acetyltransferase (Ee 2.3.1.5) activity was 
examined using skin from Syrian hamster. Two isozymes 
of arylamine N-acetyltransferase, designated NAT-l and 
NAT -2, were detected on anion-exchange high-perform-
ance liquid chromatography analysis. Both enzyme activities 
had indistinguishable molecular masses (30 kDa), but dif-
fered significantly in their specificity toward the aromatic 
amines including serotonin, dopamine, methoxytryptamine, 
tryptamine, para-phenetidine, para-aminobenzoic acid, and 
sulphamethazine. Specifically, NAT-2 but not NAT- l cata-
lyzed acetylation of dopamine to N-acetyldopamine and ace-
T he skin is the largest body organ that, besides being a physical barrier, possesses a complex defense mecha-nism against physical, chemical, and biologic stressors [1]. Thus, it is a powerful immune organ that contains an important local component of immune response-
associated cells (keratinocytes, endothelial cells, mast cells, tissue 
macrophages, T lymphocytes, and dendritic cells) [1]. It has endo-
crine functions as well, e.g., it produces vitamin D3 [2] and PTH-
like hormone [3,4], expresses proopiomelanocortin (POMe) [5], 
and is involved in steroid metabolism [6]. Furthermore, the skin 
possesses a large enzyme repertoire involved in drug and xenobiotic 
metabolism that maintains or modulates its chemical milieu [6]. 
The hamster is a rodent model with a long tradition in dermato-
logic research, particularly in contact sensitivity, wound healing, 
mast cell studies, and notably the form of the "hamster flank organ" 
assay in drug-permeability studies [7,8] . The approximately 2% 
incidence of spontaneous melanoma in hamsters makes this animal a 
valuable tool for the study of malignant transformation of melano-
cytes [9 ,10]. In addition, transplantable melanomas in hamsters 
have been used as models for pigment cell and melanoma research 
and to examine multidirectional interactions between cutaneous 
and tumor tissues [11,12]. Recent studies by Kawakubo et al [13] 
demonstrating acetyl transferase activities catalyzing N- and O-ace-
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tylation of serotonin to form N-acetylserotonin, a direct 
precursor of melatonin. The two isozymes were also 
distinguishable based upon their sensitivity toward metho-
trexate inhibition (50% inhibiting dose for NAT-l = 
380 ,11M; NAT -2 > 2 mM). The presence of these two activ-
ities in the skin raises new questions about the physiologic 
role of this enzyme in general and in the skin-specific 
functions in particular. Key words: N-acetylserotonin/N-
acetyldopamine/detoxification/melatonin. ] Invest Dennatol 
101:660-665,1993 
tylation of carcinogenic arylamines and N-hydroxylamines in ham-
sters suggest that the skin may playa role in the metabolism of 
aromatic amines. This places this animal high on the list of experi-
mental models for studies concerning cutaneous metabolism of aro-
matic amines and its relationship with skin physiology or pathol-
ogy. 
Two classes of aromatic amine N-acetyltransferase (NAT) activi-
ties have been described [14]. One of these activities, arylalkylamine 
NAT, catalyzes the acetylation of serotonin to N-acetylserotonin, 
which is the key regulatory step in the synthesis of melatonin 
[15,16]' Melatonin is synthesized in the pineal gland, retina, and 
perhaps in other peripheral sites undetected so far. It has been 
shown, for example, that lymphocytes can synthesize melatonin 
[17,18]; it also has been suggested that melatonin can be synthesized 
in the gastrointestinal tract [19]. Melatonin is an indoleamine with 
multiple regulatory functions, e.g., besides regulation of the circa-
dian rhythm, it may act as a neurotransmitter, hormone, and immu-
nomodulator [20]. The mammalian skin is one potential target 
organ for melatonin bioregulation [21]. 
The other class of NAT demonstrates a preference for arylamine 
substrates such as phenetidine and sui phamethazine; hence this class 
of activity is referred to as "arylamine NAT." Although this en-
zyme activity has been primarily studied in the liver and is thought 
to be involved in the detoxification of exogenous amines (for review 
see [22,23]), arylamine NAT activity has also been detected ill the 
hamster skin [13]. Attenuation of tills NAT activity has been asso-
ciated with several disease processes such as bladder cancer [22,23] . 
Earlier studies done primarily in rabbits and humans indicate that 
there are at least two categories of this enzyme activity, i.e., poly-
morphic and monomorphic, which can be assessed based primarily 
upon substrate specificities. This acetylation polymorphism has 
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Figure 1. Arylamine NAT activity of skin supernatant as shown by anion 
change chromatography using a WAX HPLC column. A 20-ml superna-
ex t sample of a 20% skin homogenate was loaded onto the column. The 
ta1umn was washed using equilibrating buffer and the enzyme activity was ~futed using a linear gradient ofKCI (0-1.0 M) in Tris-HCI (20 mM, pH 
73) containing 1 mM dltl1lothreltol. FractIOns (1 ml) were assayed usmg 
b~th arylamine (circle) and arylalkylamine (triaugle) submates. Two peaks of 
NAT activity are depicted. NAT-1 demonstrates specifiCity toward the ary-
lamine substrate, whereas NAT-2 acetylates both the arylamine and arylal-
kylamine substrate. Dashed lille, salt gradient. 
b en observed more recently in hamster populations as well, but t~e ~ttern of substrate acetylation is opposite to th~t o~served III 
human and rabbit [24] . Two distinct NATs were Identifie? from 
inbred hamster liver preparations in which one NAT actiVity was 
shown to be polymorphic whereas the other was classified as mono-
morphic [25 J. The amine specificities for the two types were clearly 
different from those found in the case of rabbits and. humans. . 
In the first step toward elucidation of the mechal1lsm r.egulat1l1g 
cutaneous metabolism of aromatic amines and its potential role 111 
skin physiology and pathology, we have identified and character-
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Figure 2. Concentration dependency of inhibition of NAT activity by 
MTX. Here the MTX 1050 curve following the incubation of the NAT 
sample, after the anion exchange procedure, with various concentrations 
(0-2 mM) of MTX is seen. Subsequently, NAT enzyme assays were per-
formed using the MTX-im;ubated NAT samples. Only arylaminc (circle) 
NAT activity was assayed in the case of the NAT-1 samples; however, for 
the NAT-2 samples both arylamine (circle) and aryl alkylamine (triaugleJ 
NAT activities were examined. The values plotted are the mean of duplicate 
determinations, which were within 5% of the mean. The 1050 value for 
N AT-l (aJ was determined to be 3S01lM, whereas NAT-2 (bJ did not 
demonstrate significant sensitivity toward MTX using either amine. 
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Table I. Substrate Specificity of Hamster Skin to 
Arylamine N-acetyltransferase-2° 
pmol/ min/ assay 
Amine Substrate 0.1 mM 1 mM Amine Structure 
Para-phenetidine 29.6 
Tryptamine 6.4 
Methoxytryptamine 11.0 
Serotonin O.S 
• The substrate specificity of NAT-2 was evaluated using both classes of aromatic 
amine substrates. The arylamine substrate is para-phenetidine, and the arylalkylamine 
sub~trates arc scr~ton~n, tryp~amincl and nlcthoxytryptaminc. Two substrate conccn-
tratlOns are used m tillS expenment, 0.1 mM and 1 mM, which provides a range for the 
a,mine substrates b~in~ examined. The data presented are means of duplicate dctennina-
tlons that. were wlthm 5% of the means. Similar substrate specificity patterns were 
observed 111 two separate expenments. 
ized two isozymes of arylamine NAT in hamster skin. Our results 
demo~strate two ionic species of NAT activity (NAT-l and NAT-
2)~ which, based upon substrate specificity, are classified as an aryla-
mme NAT (NAT-i) and a mixed arylamine/arylalkylamine NAT 
(NAT -2) . Furthermore, they differ in their spectrum of specificities 
as well as in other biochemical parameters. 
MATERIALS AND METHODS 
Preparation of the Enzyme Extract Male Syrian golden hamsters 
(Mesocricetus at/reauts) were purchased from Charles River, Wilmington, 
MA, housed in community cages in the Albany Medical College Animal 
Facility with 12-h light periods. and fed ad libitulIl with water and rat/mouse 
chow. Three- to six-month -old hamsters w.ere used as a source for the skin. 
The animals were sacrIficed and their hair was removed with an electrical 
animal clipper. All back skin was dissected at the level of subcutis, immedi-
ately transferred to liquid nitrogen, and stored at - SO · C. The animal proto-
cols were approved by the IACUC at the Albany Medical College . 
. A 20% homo~enatewas prepared in 20 mM Tris-HCI (pH 7.3) contain-
lllg 1 mM dld1lothreltol (OTT). The homogenate was centrifuged at 
30,000 X g for 2 h. 
Weak Anion Exchange High-Performance Liquid Chromatography 
(HPLC) Weak alllon .excha~lge (WAX) chromatography was employed 
for the analYSIS of potentlallOlllC forms of NAT activity in the crude enzyme 
preparatlons from the skll1. The supernatant (approximately 20 ml) was 
lllJectcd mto the WAX HPLC column (BioSeries. 5 cm X 7.5 mm; Mac-
Mod Anal~tical, Inc., Chadds Ford, PAl. The equilibrating buffer was 
20 mM Tns-HCl (pH 7.3) containing 1 mM dithiothreitol (flow rate, 1 
ml(,?ll1)' The effluent was collected on ice and later assayed for enzyme 
actlVlty. T he column was washed with equilibrating buffer for 10 min and 
the enzyme activity was eluted using a KCI gradient (0 - 1.0 M) in the 
equilibrating buffer. Fractions (1 ml) were collected and assayed for NAT 
activity USlllg both para-phenetidine and tryptamine (aryl amine and arylal-
kylamine substrates, respectively) . 
Size-Exclusion HPLC NAT-l and NAT-2 following the WAX HPLC 
procedure were collected separately, conceutrated using microconcentrators 
(10 k molecular weight cutoff; Amicon, Beverly, MA), and subsequently 
subjected to size-exclusion HPLC (TSK-G3000SW, 60 cm X 7.5 mm; 
Thomson Instruments, Springfield, V A) . The column was equilibrated with 
100 mM ammonium acetate (pH 7.3) containing 1 mM dithiothreitol. A 
O.s-ml sample was injected and the elution was performed using the equili-
brating buffer at a flow rate of 0.5 ml/min. Fractions (0.5 ml) were collected 
and assayed for NAT activity using both para-phenetidine and tryptamine. 
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Figure 3. N-acetylation of dopamine is depicted using reverse-phase HPLC. NAT enzyme assays were performed using dopamine as the amine acceptor. 
A,C, controls (absence of enzyme) for NAT-l (A) and NAT-2 (C) ; B,D, chromatographic results when enzyme was included in the reaction assay for NAT-! 
(B) and NAT-2 (D) . Dotted /il/e, methanol gradient (0-100%); solid lil/ e, absorbance at 280 nm; and dashed lil/e, radioactivity. 
NAT Assay A modification [14} of Oeguchi and Axelrod's [26} method 
was employed using para-phenetidine (1 mM) and tryptamine (1 mM) as the 
amine acceptors and ['H} acetyl Coenzyme~A (CoASAc, specific activity = 
20 I1Ci/l1mol, 0.1 mM final; Amersham Corp., Arlington Heights, IL) as 
the acetyl donor. A 25-111 portion of the tissue sample was incubated (37 · C, 
30 min) with 12.5 III ['H}CoASAc and 12.5 III of amine substrate, both 
prepared in 0.1 M sodium phosphate buffer (pH 7.2). The reaction was 
terminated by the addition of 1 ml of chloroform, the reaction tubes were 
vortex-mixed, and the aqueous layer was aspirated. The chloroform phase 
was washed twice with 0.2 mlofl N NaOH and a 500-111 aliquot was placed 
in a scintillation vial for evaporation; subsequently, radioactivity was mea-
sured using liquid scintillation counting. 
When assaying with serotonin, the method described by Oeguchi and 
Axelrod [26} was used with a minor modification. This modification in-
volved washing the organic phase three times with 0.2-ml aliquots of 
NaOH (1 N). All of the samples in the substrate specificity study were 
processed in this manner. 
Methotrexate (MTX) Inhibition of NAT Activity A 50% inhibiting 
dose (1050) value of methotrexate (MTX) was determined for the NAT 
activity following WAX HPLC analysis of the crude skin homogenate. 
Various concentrations of MTX (0-2 mM) were incubated (4 ·C, 24 h) 
with NAT-l and NAT-2 independently. Following a 24-h incubation, the 
enzyme assay was performed using para-phenetidine and tryptamine where 
appropriate, specifically with NAT-2. The mode of inhibition was assessed 
by performing kinetic analysis on NAT-lusing 1 mM and 2 mM MTX and 
assaying with para-phenetidine. The mathematical analysis was performed 
using Sigma Plot version 4.1. 
Reverse-Phase HPLC Analysis In order to determine the NAT activity 
for para-aminobenzoic acid (PABA) and sulfamethazine (SMZ) (both of 
which are arylamines), a reverse-phase HPLC system with radioisotope 
detection was employed. The NAT assay itself was essentially the same as 
described above (amine concentration was 1 mM and 0.1 mM). Following 
the incubation, however, the samples were processed differently. The reac-
tion was terminated with 0.2 N HCIO. (50 Ill). Approximately 90 III was 
injected into the reverse-phase HPLC column (VYOAC-C'B' 0.5 cm X 
22 cm; Princeton, NJ), which was equilibrated using 1 % glacial acetic acid 
(pH 4.0, flow rate = 1 ml/min). The elution was different depending upon 
the amine substrate used. For SMZ, the column was washed for 5 min using 
the equilibrating buffer, then a 12% isocratic elution was established using 
methanol (88: 12, acetic acid: methanol). When determining PABA acety-
lation, a 5% isocratic elution was es tablished with methanol (95: 5, acetic 
acid: methanol) following a 5-min wash with equilibrating buffer. A Beck-
man 171 radioisotope detector was employed to determine the radioactivity 
of the sample injected (efficiency = 16%); the data presented are un-
corrected. Acetylated standards were prepared by using acetic anhydride 
with the appropriate amine [27}. 
To analyze dopamine acetylation, a linear gradient using methanol was 
established. Acetic acid (1 %, pH 3.0) was used as the equilibrating buffer and 
the gradient, which employed methanol, was initiated following as-min 
wash with the equi librating buffer. The gradient continued for 55 min, until 
100% methanol was achieved. 
RESULTS 
Demonstration of Two NAT Activities in the Hamster 
Skin To address the possibility of multiple NAT species in the 
skin, an approach similar to that taken by Hein et at [25] and Grant et 
at [28] was employed . Using Syrian hamster skin supernatant pre-
pared from a 20% homogenate, the ionic characterization of the 
skin NAT activity was performed using anion-exchange chroma-
tography (Fig 1). The chromatographic profile of the anion-ex-
change procedure demonstrated that the NAT activity was bound to 
the column under the described loading conditions. Essentially no 
enzyme activity was detected in either the effluent or wash. Alter-
nate fractions were assayed using both classes of aromatic amine 
substrates (para-phenetidine and tryptamine). Two peaks of NAT 
activity were observed. The first peak of NAT activity, designated 
NAT-!, eluted approximately midway through the KCl gradient. 
Based upon substrate specificity, NAT-1 is characterized as an ary-
lamine NAT. The other NAT activity peak, which eluted follow-
ing NAT-t, demonstrates both aryl amine and arylalkylamine ace-
tylation; however, the predominant NAT activity is aryl amine. 
Arylalkylamine NAT activity accounts for approximately 75% of 
the total NAT activity in NAT-2. 
Sensitivity to MTX Inhibition is Examined To further char-
acterize NAT-! and NAT-2, we examined the behavior of each 
activity individually toward methotrexate (MTX). In previous 
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rk w e have been able to demonstrate differential sensitivity w~~d MTX inhibition [29]. Another element in the stra tegy of 
to ploying MTX is an attempt to address the question of whether ~ T -2 represents one or two sejJarate NAT activities. NAT-l and 
NAT -2 w ere incubated with vanous concentratIOns of MTX over-
. ht at 4 0 C. The following day the various preparations were 
mg yed fo r NAT activity. In the case of the NAT-2 preparations, 
assa f ' bid ' I ' both classes 0 am111e su strate were emp oye , I.e .. , ary am111e 
( ara_phenetidine) a~ld arylalkylam111e (tryptam111e). Figure 2 rep-
p ents MTX inhibition curves from which IDso values were eva]u-
res d NAT -1 clearly demonstrates sensitivity to MTX inhibition. in at~i~h the IDso value is determined to be 380 11M (Fig 2a) . In con-
w st NAT-2 appears not to be affected by MTX concentrations up 
tra 2 'ruM (Fig 2b) . Equally important is th e findi ng that both NAT 
to tiv ities behave in a similar manner, suggesting that NAT -2 IS one ~c nic NAT species with broad substrate specificity . 
10 The mode of MTX inhibition on NAT-l was assessed using 
a_phenetidine as the amine substrate. A fami ly of near-parallel 
fares were observed upon performing kinetic analys is using 0, 1, or 
~~nM MTX (data not shown). This suggests that the mode of 
inhibition is uncompetlt1ve. 
The Amine Substrate Specificity for NAT-2 is Studied To 
f the r pursue the specificity of NAT -2, we conducted a substrate 
s U~cificiry study (Table I) . Following the WAX HPLC procedure, 
J AT - 2 samples were subjected to substrate-specificity analYSIS. As 
T bIe I illustrates, clearly the predominant activity is against the 
a lamine substrate, para-phenetidine. However, it also demon-
ary ted significant activity toward arylalkylamines. This NAT :~t~vity appears to prefer the more hydrophobic ary l~lkyl amine 
b tra tes, such as tryptamine and methoxytryptamme, when 
su ~pared to serotonin, which is less hydrophobic. 
co In contrast to this findin g, Fig 3 illustrates enzyma~ic ace~lation 
of dopamine, which is less hydrophobic than serotomn. TIllS prop-
appears to be specific to NAT-2 because NAT-l shows no 
ertytylating activity toward dopamine. Acerylation occurs using 
ace h d " 1 mM dopamine with little observed w en 0.1 mM opaml~le IS 
m ployed, perhaps indicating a relatively hi gh K", for dopam111e. 
e The difference in acetylation of PABA and SMZ between NAT-l 
and NAT -2 is illustrated in Fig 4, which only represents data ob-
tained using 1 mM substrate concent~atlOn . The pattern of acetyla-
. n re m ains the same when 0.1 mM IS employed (data not shown) . ~oAT -2 clearly demonstrates the ability to acetylate SMZ (Fig 411) , 
whereas NAT-1 does not appear to acetylate this amine (~i g 4c). 
W h en the substrate is PABA, both NAT-l and NAT-2 ma111festthe 
ability to acetyl ate this molecule (Fig 4e and f, respectively). 
Size-Exclusion HPLC Size-exclusion chromatography was 
employed to furth er purify and to obtain the approximat e molecular 
mass of NAT- l and NAT-2. These two NAT activities were col-
lected separately fo llowing the WAX HPLC proce~ure, concen-
trated to 0.5 ml, and subsequently subjected to s lze-exclu s~on 
HPLC (Fig 5) . Fractions (25 - 45) were collected and assayed US111g 
both p ara-phenetidine and tryptamine. As Fig 5 illustrates, both 
NAT -1 and NAT-2 have identical retention times. NAT-l demon-
strates substantial arylamine NAT activity when compared to the 
arylalkylamine NAT activity (Fig Sa) . In contrast, Fig 5b illustrates 
significant arylalkylamine NAT activity co-eluting With the aryla-
mine NAT activity peak in NAT-2. This aryialkylamllle NAT ac-
tivity is approximately 75% that of th e arylamine NAT activity. 
DISCUSSION 
The results presented above demonstrate the presence of at least two 
isozymic form s of arylamine NAT activity in Syrian hamst~r sk111 . 
T hese two isoforms were resolved upon perfonmng amon-ex-
change HPLC of the crude supernatant. These two skin NAT iso-
form s can be furth er distinguished based on their amine substrate 
specificiry and sensitivity to inhibition by MTX. . . 
It is of interest to note that two lomc forms of NAT activity have 
been d etected earlier in the hamster liver [24]. Consistent with the 
earlier results, NAT -1, the activity eluting first on anion-exchange 
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chromatography, was least active against sulphamethazine, one of 
the most commonly used drugs employed to characterize arylamine 
NAT activity in the liver. Earlier studies [25] have also shown that 
this enzyme activity (NAT-i) exhibited polymorphic variation in 
activity among various individuals . In contrast, in other species 
examined , the polymorphic forms of th e enzyme were found to be 
highly active against sulphamethazine. It is not clear that the N AT -
1 we have detected in the skin also shows polymorphic variation. 
The enzyme activity in the liver is thought to be involved in th e 
detoxification of arylamine and hydrazine drugs [22,23] . Whether 
the enzymes in the skin also participate in a similar function remains 
unclear. Recent studies indicating that multiple forms of this en-
zyme (NAT) ac tivi ty are present in other tissues, including the brain 
[29,30], raise the distinct possibili ty that they may serve additional 
functions related to the maintenance of normal physiologic pro-
cesses. 
Our results provide insights into two such potential roles for at 
least one of the two enzyme activities, i. e., NAT-2. W e have found 
that NAT-2 acety lates a variety of arylalkylamines, incl uding sero-
tonin, with reasonable potency. This raises the possibili ty that this 
enzyme may be involved in acetylating biogenic amines either for 
detoxifying them or to generate biologically active products such as 
melatonin. Recent observations [17,1 8] that lymphocytes can syn-
thesize melatonin show that melatonin synthesis is not res tricted to 
selected tissues such as pineal and retina, as was previously thought. 
Based on this, it is reasonable to suggest that perhaps skin, a tissue in 
w hich melatonin is thought to be active , also can synthesize mela-
tonin for local use. 
The second property of NAT-2, acetylation of dopamine to N-
acetyl dopamine, is of special interest. To our knowledge this is the 
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Figure 4. Reverse-phase HPLC analysis of N AT activity using PABA and 
SMZ. NAT -1 and NAT -2 were incubated w ith 1 111M SMZ (b and c, respec-
tively) as w ell as with 1 mM PABA (eandf, respectively). a,d, assays in which 
phosphate buffer (pH 7.3, containing 1 mM OTT) plus SMZ (a) or PABA 
(d) was substituted for N AT-l and NAT-2. Solid lilies, absorbance at 280 nl11; 
dolted lilies, isocratic elution; dashed lili es, radioactivi ty. 
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Figure 5. Size-exclusion HPLC of WAX HPLC NAT-l (a) and NAT-2 
(b) activities. Fractions were collected (0.5 ml) and assayed for both aryla-
mine (para-phenetidine) and arylalkylamine (tryptamine) NAT activity. 
The molecular mass markers (arrows) used were bovine serum albumin (66 
kDa), carbonic anhydrase (29 kDa), cytochrome c (12.4 kDa), and aprotinin 
(6.5 kDa). 
first demonstration of the enzymatic acetylation of dopamine in the 
mammalian species. Although the role of this enzyme remains spec-
ulative, the significance of this reaction for tissue homeostasis can be 
envisaged. The acetylation of dopamine may playa role in the 
regulation of local tissue concentration of this biogenic amine or in 
attenuating its bioregulatory activity , for example, on the cutaneous 
vascu lar system. Alternatively, N-acetyldopamine is itself a biologi-
cally active molecule. In this context, we note that N-acetyldopa-
mine has been detected in the urine and kidney tissue of humans 
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[31- 33]. In the retina, dopamine is one of th e main negative regula-
tors of melatonin synthesis, e.g., it is released during exposure to 
light and by activating the D2 receptors on photoreceptors, which 
inhibits NAT activity [34]. This raises the intri guing possibility that 
the acetylation of dopamine may playa role in disinhibition of 
arylalkylamine NAT activity, a possibility that deserves further in-
vestigation in the retina. In the skin we have a different situation . 
NAT-2 can acetyl ate both arylamines and arylalkylamines (like do-
pamine), which opens another aspect of whether NAT -2 can mod-
ify dopamine's biologic activity via the inactivation of dopamine. 
Although these ideas are speculative, they serve to outline future 
research , which hopefully will lead to a greater understanding of 
the physiologic role that these NAT activi ties may play. 
In summary, we have identified two NAT activities, NAT-1 and 
NAT -2, with distinctly different specificity characteristics in ham-
ster skin. NAT-2 deserves special attention due to its ability to 
acetyl ate both arylamines and arylalkylamines like serotonin and 
dopamine. These findings form a background for our future studies 
on potential synthesis of melatonin in the skin as well as further 
examination of N -acety ldopamine and its role in this tissue. 
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